Kuros Biosciences Unveils the MagnetOs MIS Delivery System
Kuros Biosciences, renowned for its groundbreaking biologic technologies, recently introduced the fully commercial MagnetOs™ MIS Delivery System. This innovative system is tailored specifically for Minimally Invasive Surgical (MIS) procedures, providing a reliable solution for surgeons involved in bone graft delivery. The MagnetOs MIS is set to be a game changer in the realm of minimally invasive spine surgery.
An Overview of the MagnetOs MIS Delivery System
The MagnetOs MIS Delivery System stands out in the surgical market, being the only bone graft delivery system that is both sterile and prefilled. Unlike other systems that may require human tissue, the MagnetOs MIS streamlines the surgical process by eliminating such needs. This system also comes equipped with substantial clinical backing, ensuring it meets the highest standards of safety and efficacy.
Key Features of the MagnetOs MIS
The MagnetOs MIS Delivery System introduces several critical advantages that set it apart from traditional delivery methods:
- Always ready for use – this system is single-use, sterile, prefilled, and available off the shelf, requiring no refrigeration or thawing.
- Enhanced efficiency – the graft placement is completed three times faster than conventional funnel-based techniques.
- Designed for optimal handling – the system allows for effortless, controlled placement of grafts in challenging surgical environments.
The Scientific Backing Behind MagnetOs
Leveraging the proven science of MagnetOs and incorporating the proprietary NeedleGrip™ submicron surface technology, the MIS system not only streamlines workflow but also stimulates bone formation by effectively harnessing the body’s immune system. The combination of these technologies promises to reduce operating room time and improve overall surgical outcomes.
Expert Insights on the MagnetOs System
Dr. Matthew Maserati, a leading neurosurgeon at WellSpan Neurosurgery, is set to share his experiences with the MagnetOs MIS Delivery System at an upcoming conference. His positive feedback underscores the system’s efficiency and reliability, stating, "Kuros Biosciences has delivered an elegant solution that makes MIS graft placement efficient and reliable, without compromise. I was impressed with how seamlessly the system performed and provided confidence in delivering MagnetOs precisely into confined spaces.”
CEO’s Vision for Future Innovation
Chris Fair, the CEO of Kuros Biosciences, sees the launch of the MagnetOs MIS not merely as a product introduction but as a pivotal moment in the evolution of spine surgery. He emphasizes, "By combining efficiency, precision, and the strength of Level I clinical evidence, we’re setting a new standard for minimally invasive care. At Kuros, our mission is to empower surgeons with innovations that don’t just keep up with the future but help shape it.”
Additional Clinical Evidence
The effectiveness of the MagnetOs MIS system is further validated by published clinical evidence, highlighting a remarkable 94.4% fusion rate in patients undergoing minimally invasive surgical procedures. These outcomes support the system’s reliability as a robust option in spine surgery, particularly for patients with varying comorbidities.
About Kuros Biosciences
Kuros Biosciences is committed to discovering and delivering trailblazing biologic technologies, with facilities located in the United States, Switzerland, and the Netherlands. As an innovative leader in the medical field, Kuros has made significant strides with its flagship product, MagnetOs™, which has achieved international recognition and use across five continents. For more details on Kuros Biosciences, its innovative products, and ongoing research, visit their official website.
Frequently Asked Questions
What is the MagnetOs MIS Delivery System?
The MagnetOs MIS Delivery System is an innovative solution designed for minimally invasive surgical procedures, offering a sterile, prefilled bone graft option ready for use.
What are the key advantages of the MagnetOs MIS?
This system allows for quick, efficient graft placement, eliminates the need for human tissue, and provides sterile, off-the-shelf availability.
Who is presenting the MagnetOs MIS at the conference?
Dr. Matthew Maserati, an experienced neurosurgeon, will be presenting insights and experiences with the MagnetOs MIS system at a prominent medical meeting.
How does Kuros Biosciences contribute to spine surgery?
Kuros Biosciences is focused on developing innovative biologic technologies that enhance surgical outcomes and empower surgeons in their practice.
Where can I find more information about Kuros Biosciences?
For additional insights into Kuros Biosciences' products and their research initiatives, visit their official website.
